PD0332991 (Palbociclib) for treatment of pediatric intracranial growing teratoma syndrome

Pediatric Blood and Cancer

Volumn 62, Issue 6, 2015, Pages 1072-1074

  Schultz, Kris Ann P ^a   Petronio, Joseph ^a   Bendel, Anne ^a   Patterson, Richard ^a   Vaughn, David J ^b  

^a CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Brain tumor; Cyclin dependent kinase; Germ cell tumor; Teratoma

Indexed keywords

ALPHA FETOPROTEIN; ALPHA2B INTERFERON; CISPLATIN; PALBOCICLIB; RETINOBLASTOMA PROTEIN; ANTINEOPLASTIC AGENT; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE;

ALPHA FETOPROTEIN BLOOD LEVEL; ARTICLE; BODY HEIGHT; BRAIN BIOPSY; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CHILD; CHILD HOSPITALIZATION; CHILDHOOD CANCER; CHROMOSOME ANALYSIS; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; GAZE PARALYSIS; GERM CELL TUMOR; GROWING TERATOMA SYNDROME; HEADACHE; HUMAN; LASER THERMOTHERAPY; MALE; METAPHASE; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PINEAL BODY TUMOR; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY DISTRESS; SINGLE DRUG DOSE; TERATOMA; TUMOR BIOPSY; TUMOR GROWTH; TUMOR VOLUME; X CHROMOSOME; BRAIN NEOPLASMS;

ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CHILD, PRESCHOOL; HUMANS; PIPERAZINES; PYRIDINES; TERATOMA;

EID: 84927785981     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.25338     Document Type: Article

References (18)

1. Kim CY, Choi JW, Lee JY, Kim SK, Wang KC, Park SH, Choe G, Ahn HS, Kim IH, Cho BK. Intracranial growing teratoma syndrome: Clinical characteristics and treatment strategy. J Neurooncol 2011; 101:109-115.
2. Logothetis CJ, Samuels ML, Trindade A, Johnson DE. The growing teratoma syndrome. Cancer 1982; 50:1629-1635.
3. Lee DJ, Djaladat H, Tadros NN, Movassaghi M, Tejura T, Duddalwar V, Daneshmand S. Growing teratoma syndrome: Clinical and radiographic characteristics. Int J Urol 2014; 21:905-908.
4. Denaro L, Pluchinotta F, Faggin R, Manara R, Calderone M, Viscardi E, Gardiman M, Rossetto M, Perilongo G, d'Avella D. What's growing on? The growing teratoma syndrome. Acta Neurochir (Wien) 2010; 152:1943-1946.
5. Byrd K, Stany MP, Herbold NC, Leath CA, 3rd, Hamilton CA. G rowing teratoma syndrome: Brief communication and algorithm for management. Aust N Z J Obstet Gynaecol 2013; 53:318-321.
6. Vaughn DJ, Flaherty K, Lal P, Gallagher M, O'Dwyer P, Wilner K, Chen I, Schwartz G. Treatment of growing teratoma syndrome. N Engl J Med 2009; 360:423-424.
7. Finn RS, Crown JP, Lang I, Boer K, Bondarenko IM, Kulyk SO, Ettl J, Patel T, Schmidt M, Shparyk Y, Thummala AR, Voytko NL, Breazna A, Kim ST, Randolph S, Slamon DJ. Results of a randomized phase 2 study of PD 0332991, a cyclin-dependent kinase (CDK) 4/6 inhibitor, in combination with Letrozole vs Letrozole alone for first-line treatment of ER+/HER2- advanced breast cancer (BC). Cancer Res 2012:72: Abstract nr S1-S6.
8. Dickson MA, Tap WD, Keohan ML, D'Angelo SP, Gounder MM, Antonescu CR, Landa J, Qin LX, Rathbone DD, Condy MM, Ustoyev Y, Crago AM, Singer S, Schwartz GK. Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma. J Clin Oncol 2013; 31:2024-2028.
9. Leonard JP, LaCasce AS, Smith MR, Noy A, Chirieac LR, Rodig SJ, Yu JQ, Vallabhajosula S, Schoder H, English P, Neuberg DS, Martin P, Millenson MM, Ely SA, Courtney R, Shaik N, Wilner KD, Randolph S, Van den Abbeele AD, Chen-Kiang SY, Yap JT, Shapiro GI. Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma. Blood 2012; 119:4597-4607.
10. Parrish KE, Pokorny JL, Mittapalli RK, Bakken K, Sarkaria JN, Elmquist WF. BBB efflux pump activity limits brain 201 penetration of palbocicli (PD0332991) in glioblastoma. Mol Cancer Ther 2013;12:C81.
11. Hersmus R, de Leeuw BH, Wolffenbuttel KP, Drop SL, Oosterhuis JW, Cools M, Looijenga LH. New insights into type II germ cell tumor pathogenesis based on studies of patients with various forms of disorders of sex development (DSD). Mol Cell Endocrinol 2008; 291:1-10.
12. Yu IT, Griffin CA, Phillips PC, Strauss LC, Perlman EJ. Numerical sex chromosomal abnormalities in pineal teratomas by cytogenetic analysis and fluorescence in situ hybridization. Lab Invest 1995; 72:419-423.
13. Casalone R, Righi R, Granata P, Portentoso P, Minelli E, Meroni, Solero CL, Allegranza A. Cerebral germ cell tumor and XXY karyotype. Cancer Genet Cytogenet 1994; 74:25-29.
14. Ornadel D, Wilson A, Trask C, Ledermann J. Remission of recurrent mature teratoma with interferon therapy. JR Soc Med 1995; 88:533P-534P.
15. Khatua S, Dhall G, O'Neil S, Jubran R, Villablanca JG, Marachelian A, Nastia A, Lavey R, Olch AJ, Gonzalez I, Gilles F, Nelson M, Panigrahy A, McComb G, Krieger M, Fan J, Sposto R, Finlay JL. Treatment of primary CNS germinomatous germ cell tumors with chemotherapy prior to reduced dose whole ventricular and local boost irradiation. Pediatr Blood Cancer 2010; 55:42-46.
16. Calaminus G, Kortmann R, Worch J, Nicholson JC, Alapetite C, Garre ML, Patte C, Ricardi U, Saran F, Frappaz D. SIOP CNS GCT 96: Final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease. Neuro Oncol 2013; 15:788-796.
17. Kretschmar C, Kleinberg L, Greenberg M, Burger P, Holmes E, Wharam M. Pre-radiation chemotherapy with response-based radiation therapy in children with central nervous system germ cell tumors: A report from the Children's Oncology Group. Pediatr Blood Cancer 2007; 48:285-291.
18. Glass T, Cochrane DD, Rassekh SR, Goddard K, Hukin J. Growing teratoma syndrome in intracranial non-germinomatous germ cell tumors (iNGGCTs): A risk for secondary malignant transformation-a report of two cases. Childs Nerv Syst 2014; 30:953-959.